COVID-19 Simulation Education on Nursing Students

July 10, 2023 updated by: Nurten Terkes, Mehmet Akif Ersoy University

The Effect of Simulation Education as an Approach to Patients With COVID-19 on Nursing Students' Perception and Fear of COVID-19 Disease: A Randomized Controlled Trial

This study aims to determine the effect of simulation education as an approach to patients with COVID-19 on nursing students' perception and fear of the COVID-19 disease. This study was conducted in a randomized controlled trials with 86 nursing students from a university between November 10 and December 10, 2021.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Burdur, Turkey, 15000
        • Burdur Mehmet Akif Ersoy University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Nursing student and
  • Agreeing to participate in the study

Exclusion Criteria:

  • Refusing to participate in the study or quitting the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control Group
The control group didn't apply any interference during the study. Participants in the control group continued their routine follow-up.
Other: Control Group
The control group didn't apply any interference during the study. Participants in the control group continued their routine follow-up.
Experimental: Intervention group
After the pre-tests (the COVID-19 Disease Perception Scale, and the Fear of COVID-19 Scale) , the students were given simulation education for one months.
Behavioral: Simulation training
Expectations regarding the scenario were explained to the participants before the implementation. They were given information about the standard patient. Roles were distributed, and the implementation time of the scenario was announced. Written permission was obtained from students involved in the scenario. The intervention group was given scenario-based education appropriate for the approach to a standard patient with COVID-19. During the implementation of the scenario, the instructor did not interfere with students, and after the feedback, the "show-do" method was used to improve the incorrect skill steps. Two instructors evaluated students' performance on the standard patient simulation as "achieved-failed" and the application was recorded as a pre-test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Approach to COVID-19 Patient Form
Time Frame: 5 Minute
This form was created by the researchers following a review of the literature (Collado-Boira et al., 2020; Cervera-Gasch, Gonz ́alez-Chorda ́, & Mena-Tudela, 2020; Kurt, & Dalkıran, 2021; Ulenaers, et al., 2021; Işık, Konuş, & Bakar, 2021) and was evaluated by 3 experts who had a PhD degree in the field, and necessary improvements were made in line with their suggestions. It consists of 14 items in total. This form includes interventions, such as "The mask should be worn before entering the patient room or care area" and "Disposable respiratory and face masks should be removed and discarded after leaving the patient's room or care area and closing the door." The correct application of these interventions was scored with "1 point" and the incorrect application with "0 points". Scores range between 0 and 14. As the scores increase, the accuracy level of the approach to the patient increases, as well.
5 Minute
The Fear of COVID-19 Scale
Time Frame: 5 Minute
This scale was developed by Ahorsu et al. (2022), and its Turkish adaptation, validity, and reliability studies were performed by Ladikli et al. (2020). The scale has a single factor structure and consists of seven 5-point Likert-type (1 = strongly disagree; 5 = strongly agree) items. Scores on the scale range between 7 and 35. The higher the score is, the higher the fear of the COVID-19 pandemic is. Cronbach's alpha value of the scale is 0.82 (Ladikli et al., 2020).
5 Minute
The COVID-19 Disease Perception Scale
Time Frame: 5 Minute
This scale was developed by Geniş et al. (2020). It consists of seven items. It has a five-point Likert-type structure and consists of two sub-dimensions. The total score is calculated by summing the scores of the items on the sub-dimension and dividing the results by the number of items on that sub-dimension. This operation yields a value between 1 and 5. High scores on the dangerousness sub-dimension indicate that the perceived dangerousness of the disease is high, and high scores on the contagiousness sub-dimension indicate that the perceived contagiousness of the disease is high. Cronbach's alpha value of the original scale is 0.78 (Geniş et al., 2020).
5 Minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mehmet Akif Ersoy University

Investigators

  • Study Chair: Sibel Senturk, PhD, Burdur Mehmet Akif Ersoy University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 10, 2021

Primary Completion (Actual)

December 10, 2021

Study Completion (Actual)

September 10, 2022

Study Registration Dates

First Submitted

October 7, 2022

First Submitted That Met QC Criteria

October 11, 2022

First Posted (Actual)

October 12, 2022

Study Record Updates

Last Update Posted (Actual)

July 11, 2023

Last Update Submitted That Met QC Criteria

July 10, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MAKU-GO 2021/357

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

All authors contributed to the interpretation, writing, and approval of the final manuscript.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe